110 related articles for article (PubMed ID: 17329684)
21. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
[TBL] [Abstract][Full Text] [Related]
22. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density.
van Dijke CF; Brasch RC; Roberts TP; Weidner N; Mathur A; Shames DM; Mann JS; Demsar F; Lang P; Schwickert HC
Radiology; 1996 Mar; 198(3):813-8. PubMed ID: 8628876
[TBL] [Abstract][Full Text] [Related]
23. [Chemopreventive effect of celecoxib against DMBA-induced breast cancer and its mechanism].
Kang HF; Wang XJ; Liu XX; Dai ZJ; Xue FJ; Xue XH
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1599-602. PubMed ID: 17121709
[TBL] [Abstract][Full Text] [Related]
24. Individual and combined effects of selective cyclooxygenase-2 inhibitor and omega-3 fatty acid on endotoxin-induced periodontitis in rats.
Vardar S; Buduneli E; Baylas H; Berdeli AH; Buduneli N; Atilla G
J Periodontol; 2005 Jan; 76(1):99-106. PubMed ID: 15830643
[TBL] [Abstract][Full Text] [Related]
25. Selective inhibition of cyclooxygenase-2 suppresses metastatic disease without affecting primary tumor growth in a murine model of Ewing sarcoma.
Gendy AS; Lipskar A; Glick RD; Steinberg BM; Edelman M; Soffer SZ
J Pediatr Surg; 2011 Jan; 46(1):108-14. PubMed ID: 21238650
[TBL] [Abstract][Full Text] [Related]
26. Assessing tumor angiogenesis using macromolecular MR imaging contrast media.
Brasch R; Pham C; Shames D; Roberts T; van Dijke K; van Bruggen N; Mann J; Ostrowitzki S; Melnyk O
J Magn Reson Imaging; 1997; 7(1):68-74. PubMed ID: 9039595
[TBL] [Abstract][Full Text] [Related]
27. Dynamic contrast-enhanced magnetic resonance imaging at 1.5 Tesla with gadopentetate dimeglumine to assess the angiostatic effects of anginex in mice.
de Lussanet QG; Beets-Tan RG; Backes WH; van der Schaft DW; van Engelshoven JM; Mayo KH; Griffioen AW
Eur J Cancer; 2004 May; 40(8):1262-8. PubMed ID: 15110892
[TBL] [Abstract][Full Text] [Related]
28. Assessment of bone marrow angiogenesis in patients with acute myeloid leukemia by using contrast-enhanced MR imaging with clinically approved iron oxides: initial experience.
Matuszewski L; Persigehl T; Wall A; Meier N; Bieker R; Kooijman H; Tombach B; Mesters R; Berdel WE; Heindel W; Bremer C
Radiology; 2007 Jan; 242(1):217-24. PubMed ID: 17116730
[TBL] [Abstract][Full Text] [Related]
29. Combinational chemoprevention effect of celecoxib and an oral antiangiogenic LHD4 on colorectal carcinogenesis in mice.
Kim JY; Alam F; Chung SW; Park J; Jeon OC; Kim SY; Son WC; Byun Y
Anticancer Drugs; 2014 Oct; 25(9):1061-71. PubMed ID: 25003253
[TBL] [Abstract][Full Text] [Related]
30. Approach to angiogenesis inhibition based on cyclooxygenase-2.
Masferrer J
Cancer J; 2001; 7 Suppl 3():S144-50. PubMed ID: 11779086
[TBL] [Abstract][Full Text] [Related]
31. DCE-MRI biomarkers for monitoring an anti-angiogenic triple combination therapy in experimental hypopharynx carcinoma xenografts with immunohistochemical validation.
Sterzik A; Paprottka PM; Zengel P; Hirner H; Roßpunt S; Eschbach R; Moser M; Havla L; Ingrisch M; Mack B; Reiser MF; Nikolaou K; Cyran CC
Acta Radiol; 2015 Mar; 56(3):294-303. PubMed ID: 24609871
[TBL] [Abstract][Full Text] [Related]
32. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.
Reddy BS; Hirose Y; Lubet R; Steele V; Kelloff G; Paulson S; Seibert K; Rao CV
Cancer Res; 2000 Jan; 60(2):293-7. PubMed ID: 10667579
[TBL] [Abstract][Full Text] [Related]
33. Magnetic resonance imaging in an orthotopic rat model: blockade of epidermal growth factor receptor with EMD72000 inhibits human pancreatic carcinoma growth.
Bangard C; Gossmann A; Papyan A; Tawadros S; Hellmich M; Bruns CJ
Int J Cancer; 2005 Mar; 114(1):131-8. PubMed ID: 15523683
[TBL] [Abstract][Full Text] [Related]
34. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
35. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
Merz M; Komljenovic D; Semmler W; Bäuerle T
Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer.
Barnes NL; Warnberg F; Farnie G; White D; Jiang W; Anderson E; Bundred NJ
Br J Cancer; 2007 Feb; 96(4):575-82. PubMed ID: 17285134
[TBL] [Abstract][Full Text] [Related]
37. Monitoring anti-angiogenic therapy in colorectal cancer murine model using dynamic contrast-enhanced MRI: comparing pixel-by-pixel with region of interest analysis.
Haney CR; Fan X; Markiewicz E; Mustafi D; Karczmar GS; Stadler WM
Technol Cancer Res Treat; 2013 Feb; 12(1):71-8. PubMed ID: 22905809
[TBL] [Abstract][Full Text] [Related]
38. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
Meier R; Henning TD; Boddington S; Tavri S; Arora S; Piontek G; Rudelius M; Corot C; Daldrup-Link HE
Radiology; 2010 May; 255(2):527-35. PubMed ID: 20413763
[TBL] [Abstract][Full Text] [Related]
39. Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience.
Gossmann A; Okuhata Y; Shames DM; Helbich TH; Roberts TP; Wendland MF; Huber S; Brasch RC
Radiology; 1999 Oct; 213(1):265-72. PubMed ID: 10540670
[TBL] [Abstract][Full Text] [Related]
40. Contrast-enhanced MR imaging assessment of tumor capillary permeability: effect of irradiation on delivery of chemotherapy.
Schwickert HC; Stiskal M; Roberts TP; van Dijke CF; Mann J; Mühler A; Shames DM; Demsar F; Disston A; Brasch RC
Radiology; 1996 Mar; 198(3):893-8. PubMed ID: 8628889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
